LRRC15 and triple-negative breast carcinoma: LRRC15 has emerged as a marker for cancer-associated fibroblasts, and numerous studies have demonstrated its high expression in various solid tumor types, including triple-negative breast cancer, head and neck cancer, non-small-cell lung cancer, pancreatic cancer, ovarian cancer, and osteosarcoma [34,35,36,37,38].